Gastrointestinal bleeding in hospitalized COVID?19 patients: a propensity score matched cohort study

Background and Aims Gastrointestinal (GI) bleeding has been observed amongst patients hospitalized with COVID-19. Recently, anticoagulation shown to decrease mortality, but it is unclear whether this contributes increased GI bleeding. The aims of study are: (i) examine there are risk factors for in COVID-19 (ii) a mortality difference between without Methods This propensity score matched case–control from large health system the New York metropolitan area March 1st April 27th. were 1:1 using that took into account comorbidities, demographics, length stay. Results Of 11, 158 COVID-19, 314 identified point prevalence was 3%. There no identifiable Use medication or antiplatelet agents not associated patients. For who developed bleed during hospitalization, an group (OR 1.58, P = 0.02). Conclusion cohort Those hospitalization had mortality.